China National Accord Medicines Corporation Ltd. (SHE:000028)

Market Cap	13.20B -1.3%
Revenue (ttm)	73.42B -1.3%
Net Income	1.14B +76.8%
EPS	2.04 +77.4%
Shares Out	556.57M
PE Ratio	12.47
Forward PE	11.32
Dividend	0.37 (1.45%)
Ex-Dividend Date	Jun 25, 2025

Volume	2,184,450
Average Volume	4,152,851
Open	26.08
Previous Close	25.44
Day's Range	25.32 - 26.08
52-Week Range	23.68 - 27.43
Beta	0.31
RSI	46.95
Earnings Date	Apr 2, 2026

About SHE:000028

China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. The company offers prescription drugs for various illnesses and medications requiring long-term use, such as oncology, liver disease, neurology, psychiatry, cardiovascular, and rheumatology/immunology. It also provides traditional Chinese medicine, Western medicine, rehabilitation therapy, and various medical-related resources through retail and medical service stores, as well as chemical drugs, OTC dr...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1993
• Employees: 39,449
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000028

Financial Performance

In 2025, SHE:000028's revenue was 73.42 billion, a decrease of -1.29% compared to the previous year's 74.38 billion. Earnings were 1.14 billion, an increase of 76.80%.